COMP <GO>
DOC vs JPM // NET PROFIT MARGIN
Healthpeak Properties Inc. (NYSE) VS. JPMorgan Chase & Co. (NYSE) • 15-METRIC TALLY: DOC 4
— JPM 7
▲ NET PROFIT MARGIN LEADER: JPM
LAST: $18.94 (+2.10%) • MKT CAP: $13.06B
net-margins
11.80%
LAST: $343.58 (+1.26%) • MKT CAP: $913.30B
net-margins
32.63%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DOC VS. JPM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DOC | JPM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.60% | 17.37% | -16.77 | JPM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 95.0x | 9.7x | +85.33 | JPM | /valuation <GO> |
| Free Cash Flow Yield | 9.38% | -18.14% | +27.52 | DOC | /fcf-yield <GO> |
| Operating Margin | 14.40% | 42.07% | -27.67 | JPM | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 11.80% | 32.63% | -20.83 | JPM | /net-margins <GO> |
| Revenue Growth (YoY) | 6.20% | 13.53% | -7.33 | JPM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 6.50% | 1.96% | +4.54 | DOC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 2/9 | +6.00 | DOC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 4.84% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.7 | 55.1 | -9.40 | JPM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 1.00 | +0.02 | DOC | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 13.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $13.06B | $913.30B | -$900.24B | JPM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DOC REV | JPM REV | DOC GROSS % | JPM GROSS % | DOC FCF | JPM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $604.0M | $182.45B | — | — | $1.22B | -$147.78B |
| FY 2024 | $568.5M | $177.56B | — | — | $1.04B | -$42.01B |
| FY 2023 | $527.4M | $158.10B | — | — | $932.5M | $12.97B |
| FY 2022 | — | $128.69B | — | — | — | $107.12B |
| FY 2021 | — | $121.65B | — | — | — | $78.08B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DOC // BETA 1.02
JPM // BETA 1.00